Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 460

1.

Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study.

Davidson J, Rothbaum BO, Tucker P, Asnis G, Benattia I, Musgnung JJ.

J Clin Psychopharmacol. 2006 Jun;26(3):259-67. Erratum in: J Clin Psychopharmacol. 2006 Oct;26(5):473. Dosage error in article text.

PMID:
16702890
2.

Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial.

Davidson J, Baldwin D, Stein DJ, Kuper E, Benattia I, Ahmed S, Pedersen R, Musgnung J.

Arch Gen Psychiatry. 2006 Oct;63(10):1158-65.

PMID:
17015818
3.

A pooled analysis of gender and trauma-type effects on responsiveness to treatment of PTSD with venlafaxine extended release or placebo.

Rothbaum BO, Davidson JR, Stein DJ, Pedersen R, Musgnung J, Tian XW, Ahmed S, Baldwin DS.

J Clin Psychiatry. 2008 Oct;69(10):1529-39.

PMID:
19192435
4.

Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.

Lenox-Smith AJ, Jiang Q.

Int Clin Psychopharmacol. 2008 May;23(3):113-9. doi: 10.1097/YIC.0b013e3282f424c2.

PMID:
18408525
5.

Effects of venlafaxine extended release on resilience in posttraumatic stress disorder: an item analysis of the Connor-Davidson Resilience Scale.

Davidson J, Baldwin DS, Stein DJ, Pedersen R, Ahmed S, Musgnung J, Benattia I, Rothbaum BO.

Int Clin Psychopharmacol. 2008 Sep;23(5):299-303. doi: 10.1097/YIC.0b013e32830c202d.

PMID:
18703940
6.

Affective and anxiety comorbidity in post-traumatic stress disorder treatment trials of sertraline.

Brady KT, Clary CM.

Compr Psychiatry. 2003 Sep-Oct;44(5):360-9.

PMID:
14505296
7.
8.

A randomized controlled trial of venlafaxine ER and paroxetine in the treatment of outpatients with panic disorder.

Pollack M, Mangano R, Entsuah R, Tzanis E, Simon NM, Zhang Y.

Psychopharmacology (Berl). 2007 Oct;194(2):233-42. Epub 2007 Jun 23. Erratum in: Psychopharmacology (Berl). 2008 Feb;196(2):339. Zhang, Ying [added].

PMID:
17589833
9.

The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases.

Keller MB, Trivedi MH, Thase ME, Shelton RC, Kornstein SG, Nemeroff CB, Friedman ES, Gelenberg AJ, Kocsis JH, Dunner DL, Hirschfeld RM, Rothschild AJ, Ferguson JM, Schatzberg AF, Zajecka JM, Pedersen RD, Yan B, Ahmed S, Musgnung J, Ninan PT.

J Clin Psychiatry. 2007 Aug;68(8):1246-56.

PMID:
17854250
10.

Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder.

Liebowitz MR, Gelenberg AJ, Munjack D.

Arch Gen Psychiatry. 2005 Feb;62(2):190-8.

PMID:
15699296
11.

A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.

Pollack MH, Lepola U, Koponen H, Simon NM, Worthington JJ, Emilien G, Tzanis E, Salinas E, Whitaker T, Gao B.

Depress Anxiety. 2007;24(1):1-14.

PMID:
16894619
12.

Open-label trial of escitalopram in the treatment of posttraumatic stress disorder.

Robert S, Hamner MB, Ulmer HG, Lorberbaum JP, Durkalski VL.

J Clin Psychiatry. 2006 Oct;67(10):1522-6.

PMID:
17107242
13.

Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial.

Brady K, Pearlstein T, Asnis GM, Baker D, Rothbaum B, Sikes CR, Farfel GM.

JAMA. 2000 Apr 12;283(14):1837-44.

PMID:
10770145
14.

Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.

Hewett K, Chrzanowski W, Schmitz M, Savela A, Milanova V, Gee M, Krishen A, Millen L, Leary MO, Modell J.

J Psychopharmacol. 2009 Jul;23(5):531-8. doi: 10.1177/0269881108089602. Epub 2008 Jul 17.

PMID:
18635695
15.

Efficacy of Venlafaxine ER in patients with social anxiety disorder: a double-blind, placebo-controlled, parallel-group comparison with paroxetine.

Allgulander C, Mangano R, Zhang J, Dahl AA, Lepola U, Sjödin I, Emilien G; SAD 388 Study Group.

Hum Psychopharmacol. 2004 Aug;19(6):387-96.

PMID:
15303242
16.

Relapse prevention of panic disorder in adult outpatient responders to treatment with venlafaxine extended release.

Ferguson JM, Khan A, Mangano R, Entsuah R, Tzanis E.

J Clin Psychiatry. 2007 Jan;68(1):58-68.

PMID:
17284131
18.

Fluoxetine versus placebo in posttraumatic stress disorder.

Martenyi F, Brown EB, Zhang H, Prakash A, Koke SC.

J Clin Psychiatry. 2002 Mar;63(3):199-206.

PMID:
11926718
19.

Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder.

Davidson JR, Rothbaum BO, van der Kolk BA, Sikes CR, Farfel GM.

Arch Gen Psychiatry. 2001 May;58(5):485-92.

PMID:
11343529
20.

Venlafaxine extended release in the short-term treatment of depressed and anxious primary care patients with multisomatoform disorder.

Kroenke K, Messina N 3rd, Benattia I, Graepel J, Musgnung J.

J Clin Psychiatry. 2006 Jan;67(1):72-80.

PMID:
16426091

Supplemental Content

Support Center